-
Functional Areas
- Principal Recipient Start-Up
-
Legal Framework
- Overview
- Project Document
-
The Grant Agreement
- UNDP-Global Fund Grant Regulations
- Grant Confirmation
- Grant Confirmation: Face Sheet
- Grant Confirmation: Conditions
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Implementation Letters and Performance Letters
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Signing Legal Agreements and Requests for Disbursement
- Language of the Grant Agreement and other Legal Instruments
- Amending Legal Agreements
- Other Legal and Implementation Considerations
- Legal Framework for Other UNDP Support Roles
-
Health Product Management
- Overview - Health Product Management
- UNDP Quality Assurance Policy
- Product Selection
- Quantification and Forecasting
- Supply Planning of Health Products
-
Sourcing and regulatory aspects
- Global Health Procurement Center (GHPC)
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Health Procurement Architecture
- Local Procurement of health products
- Procurement of Pharmaceutical Products
- Procurement of non-pharmaceutical Health Products
- Other Elements of the UNDP Procurement Architecture
- Submission of GHPC CO Procurement Request Form
- Guidance on donations of health products
- International freight, transit requirements and use of INCOTERMS
- Inspection and Receipt
- Storage
- Inventory Management
- Distribution
- Quality monitoring of health products
- Waste management
- Rational use
- Pharmacovigilance
- Risk Management for PSM of health products
- Compliance with the Global Fund requirements
- UNDP Health PSM Roster
-
Financial Management
- Overview
- Grant-Making and Signing
- Grant Implementation
- Sub-recipient Management
- Grant Reporting
- Grant Closure
- CCM Funding
- Import duties and VAT / sales tax
-
Monitoring and Evaluation
- Overview
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- Monitoring and Evaluation Components of Grant Making
- M&E Components of Grant Implementation
- Sub-Recipient Management
- Grant Reporting
-
Capacity development and transition, strengthening systems for health
- Overview
- Interim Principal Recipient of Global Fund Grants
- A Strategic Approach to Capacity Development
- Resilience and Sustainability
- Legal and Policy Enabling Environment
- Functional Capacities
- Capacity Development and Transition
- Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Capacity development and Transition Planning Process
- Capacity Development and Transition - Lessons Learned
-
Risk Management
- Overview
- Introduction to Risk Management
-
Risk Management in the Global Fund
- Global Fund Risk Management Framework
- Local Fund Agent
- Challenging Operating Environment (COE) Policy
- Additional Safeguard Policy
- Global Fund Risk Management Requirements for PRs
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Review of Risk Management During Grant Implementation
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Risk management in crisis settings
- Audit and Investigations
- Human rights, key populations and gender
- Human resources
-
Grant closure
- Overview
- Terminology and Scenarios for Grant Closure Process
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
Procurement of non-pharmaceutical Health Products
Practice PointerTo identify the channel to use for sourcing health products, please refer to the Health Procurement Architecture. If you are unable to find the product category under the Health Procurement Architecture, please contact the GHPC Health Procurement Services Team, based in UNDP, Copenhagen.
The UNDP Bureau for Management Services (BMS) Office of Procurement (OP) has established multiple Long-Term Agreements (LTAs) with commercial partners (manufacturers & suppliers/wholesalers) for the supply of non-pharmaceutical health products, such as point-of-care diagnostic kits, laboratory diagnostic systems, medical equipment and consumables, medical waste management and consumables, medical consumables, and vector control products that meet the minimum UNDP quality assurance requirements.
UNDP has established LTAs directly with manufacturers for insecticide treated nets, a sub-set of rapid diagnostic tests, and a sub-set of laboratory diagnostic systems. UNDP has established LTAs with a range of suppliers/wholesalers for all other non-pharmaceutical health products.
All LTAs for health products that have been established centrally by the GHPC are closed and are only available for use by the GHPC HPS team.
The GHPC procurement team in Copenhagen conducts the procurement process on behalf of the CO for Global Fund programmes and for other health programmes.
Beyond these UNDP LTAs, UNDP engages the services of other UN agencies to support procurement of reproductive health products.
Reproductive health products (including condoms and lubricants)
UNDP has a Memorandum of Understanding (MOU) with the United Nations Population Fund (UNFPA) for Reproductive health products (including condoms and lubricants). The MoU between UNDP and UNFPA can be accessed here.
A Formal written Procurement Services (PS) request will be submitted by GFPHST to UNFPA request UNFPA[at]unfpa[dot]org
Practice PointerWhere UNDP relies on other United Nations agencies to assist with the procurement of specific categories of health products and where there are specific cases in which these UN agencies are unable to provide support, alternative arrangements will need to be made to procure products which are compliant with UNDP quality assurance requirements. In this case, the GHPC Health Procurement Services team will need to be informed, and can advise the CO on how to proceed.
Additional guidance to support this area of work are also available through resources listed below: